GLP-3R 30mg
Triple agonist research peptide studied for coordinated GLP-1, GIP, and glucagon receptor signaling in metabolic pathway models.
Compound Overview
GLP-3R is a triple agonist research peptide evaluated in laboratory environments for its interaction with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor pathways. Compounds with multi-receptor agonist activity are studied for their coordinated signaling effects across several metabolic regulatory systems.
In experimental research models, triple agonist peptides are commonly examined for receptor-binding dynamics, intracellular signaling cascades, and endocrine pathway interactions. Investigations often explore metabolic regulation mechanisms, energy-balance signaling pathways, and the integrated activity of incretin and glucagon-associated systems.
Receptor Activity
Studied for coordinated activity at GLP-1, GIP, and glucagon receptors within integrated metabolic signaling models.
Metabolic Research Focus
Frequently evaluated in laboratory studies involving endocrine regulation, incretin signaling interactions, and energy metabolism pathways.
Laboratory Classification
Classified as a triple agonist peptide for experimental and analytical research applications.
Product Specifications
- Product Name: GLP-3R
- Peptide Type: Triple agonist research peptide
- Target Pathways: GLP-1, GIP, and glucagon receptor signaling
- Quantity: 30mg per vial
- Form: Lyophilized peptide powder
- Intended Use: Research use only
Be the first to review “GLP-3R 30mg”
Related products
Reviews
There are no reviews yet.